Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

INTRODUCTION: Introduction of new antibiotics enabling single-dose administration, such as oritavancin may significantly impact site of care decisions for patients with acute bacterial skin and skin structure infections (ABSSSI). This analysis compared the efficacy of single-dose oritavancin with mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Deck, Daniel H., Jordan, Jennifer M., Holland, Thomas L., Fan, Weihong, Wikler, Matthew A., Sulham, Katherine A., Ralph Corey, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019975/
https://www.ncbi.nlm.nih.gov/pubmed/27370913
http://dx.doi.org/10.1007/s40121-016-0119-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019975/
https://www.ncbi.nlm.nih.gov/pubmed/27370913
http://dx.doi.org/10.1007/s40121-016-0119-9

Ejemplares similares